Johnson & Johnson Equity-NMS: JNJ

Healthcare

Drug Manufacturers - General

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :	$206.67
Open :	$206.49
Today's high :	$207.81
Today's low :	$205.94
52W low :	$136.504
52W high :	$207.81
1Y :	33.49%
5Y :	43.46%
EPS(TTM): :	10.34
Shares O/S :	2.41 B
Market cap :	500.07 B

What is the share price of Johnson & Johnson today?

Johnson & Johnson (JNJ) share price as of November 28, 2025, is $207.56. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Johnson & Johnson?

Yes, Indian Investors can invest in the Johnson & Johnson (JNJ) Share by opening an international trading account with Angel One.

How can I purchase Johnson & Johnson shares in India?

Purchasing Johnson & Johnson (JNJ) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Johnson & Johnson (JNJ) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Johnson & Johnson?

Yes, you can purchase fractional shares of Johnson & Johnson (JNJ) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Johnson & Johnson?

The market capitalization of Johnson & Johnson on November 28, 2025, is $500.07 B.

In which sector Johnson & Johnson belongs?

Johnson & Johnson operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.

What documents are required to invest in Johnson & Johnson stocks?

In order to invest in Johnson & Johnson (JNJ) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Johnson & Johnson and its subsidiaries are engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company’s segments include Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, cardiovascular and metabolism. Its products include REMICADE (infliximab), SIMPONI (golimumab), SIMPONI ARIA (golimumab), STELARA (ustekinumab), TREMFYA (guselkumab), EDURANT (rilpivirine), and INVEGA SUSTENNA/XEPLION (paliperidone palmitate). The MedTech segment includes a portfolio of products used in cardiovascular, orthopedics, surgery, and vision categories. The Cardiovascular portfolio includes electrophysiology products to treat heart rhythm disorders and circulatory restoration products (Shockwave) for the treatment of calcified coronary artery disease (CAD) and peripheral artery disease (PAD).